1ere photo de l’année avec le plus beau des habits🥹

Lmao super creative and funny 😂🤣

Pourquoi devenir fellow en neurologie surspécialisée au CHUM? Nous offrons des fellowships en neurologie vasculaire, epilepsie, neuro-immunologie, trouble du mouvement, neuro-oncologie, et céphalée 🧠 👇🏼 youtu.be/7dOb3wsY4Cc?si…

Je poste un peu mon travail ici. Mon quotidien , ma réalité, ma frustration,ma passion et ma persévérance.

2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association ahajournals.org/doi/10.1161/ST…

#STROKE Guidelines in Action 🗒️: For mild non-disabling stroke ≤4.5h, IVT is not recommended. DAPT should be considered to reduce early recurrence. Ticagrelor + aspirin may be an option in selected patients with noncardioembolic stroke. ahajrnls.org/4raYcnM

Stroke accounts for 4-6% of maternal deaths in the U.S. and remains a rare but life-threatening complication of pregnancy, with significant implications for both maternal and fetal health. This scientific statement addresses key information related to maternal stroke in

This scientific statement reviews the rationale, established and emerging evidence, and strategic approaches for improving early recognition and intervention for poststroke spasticity. It also outlines strategies to close gaps in recognition and care, including expanding and

Great 👌🏾

This paper discusses cancer-related stroke, potential mechanisms, clinical care and offers a new classification novel classification for ischemic stroke attributed to cancer. ✍🏼 Mary Cushman 🫀🧠🩸 Tochi Okwuosa #GlobalEquityinHealth #CardioOnc

In acute central retinal artery occlusion treated within 4.5 hours after onset, intravenous tenecteplase did not result in greater recovery of vision at 30 days than aspirin and was associated with serious safety concerns. Full phase 3 TenCRAOS trial results and Research Summary:

It’s difficult to get pts with CRAO ( central retinal art occlusion) within 4.5 hours to the angiographic lab for Endo vascular reperfusion. That’s probably why the TenCRAOS investigators tried IVT with Tenecteplase for CRAO. Analysis showed no benefit and possible harm (NEJM

CREST-2 results presented at #ISC26

We spent a decade perfecting recanalization. CHOICE-2 reminds us outcomes don’t end at TICI 2b. EVT alone: “We’re done here.” EVT + IA tPA: “Let’s actually finish the job.” mRS 0–1: 57.5% vs 42.9% Absolute benefit 15%. p = 0.002 Microvascular no-reflow is real. CHOICE-2 just

#OCEANIC-STROKE just presented at #ISC26  showing #Asundexian is associated with reduced #ischemic #stroke in patients with non-cardioembolic stroke or high risk #TIA receiving antiplatelet therapy! AHA Science Stroke AHA/ASA SVIN Stroke: Vascular and Interventional Neurology JAHA

Tolérance zéro à l'égard des mutilations génitales féminines. #Cameroon #StopVBG

Maintenant il y’a plus de raison pour ne plus recevoir ou envoyer l’argent du 11 février et de la Saint Valentin avec Roam tout devient plus facile. N’oubliez pas de cliquer sur le lien: withroamapp.onelink.me/clbf/2r8p7351

#ISC2026 Day 3 Plenary Session. Roller coaster with MeVO today and new cerebroprotection molecule on the block AHA Science Stroke AHA/ASA